CFM
SANA icon

Compass Financial Management’s Sana Biotechnology SANA Stock Holding History

Compass Financial Management’s Portfolio SANA Stock Details SANA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.82K Buy
+1,095
New +$3.53K ﹤0.01% 1228

Other funds holding SANA

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
MG
Marex Group London $23.6B AUM 57.16% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Compass Financial Management's SANA Position: Q2 2026 in Review

Compass Financial Management opened a new position in Sana Biotechnology (SANA) in Q2 2026: 1,095 shares worth $3.82K. The stake represents ﹤0.01% of the portfolio and ranks #1228 among its holdings.

197 funds tracked by Wall St. Rank hold SANA as of Q2 2026.

  • Compass Financial Management held 1,095 shares of Sana Biotechnology worth $3.82K as of Q2 2026.
  • Sana Biotechnology was a new Compass Financial Management position in Q2 2026.
  • Sana Biotechnology made up ﹤0.01% of Compass Financial Management's portfolio in Q2 2026, its #1228 holding.
  • 197 funds tracked by Wall St. Rank held Sana Biotechnology as of Q2 2026.

Based on Compass Financial Management's 13F filing for Q2 2026, filed 12 Aug 2026.